We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.7B
AUM Growth
+$2.29B
Cap. Flow
-$32.1M
Cap. Flow %
-0.12%
Top 10 Hldgs %
20.24%
Holding
1,391
New
180
Increased
435
Reduced
508
Closed
107

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$63.6M
2
AAPL icon
Apple
AAPL
+$62.1M
3
PFE icon
Pfizer
PFE
+$59M
4
VAR
Varian Medical Systems, Inc.
VAR
+$45.4M
5
LIN icon
Linde
LIN
+$43.6M

Sector Composition

Rank Sector Weight
1 Technology 30.03%
2 Healthcare 18.47%
3 Consumer Discretionary 11.65%
4 Financials 9.99%
5 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSA
601
DELISTED
National Storage Affiliates Trust
NSA
$4.96M 0.02%
151,800
-9,200
-6% -$295K
DRNA
602
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$4.94M 0.02%
274,659
+47,243
+21% +$978K
MUSA icon
603
Murphy USA
MUSA
$9.67B
$4.91M 0.02%
38,300
-59,700
-61% -$7.9M
MDRX
604
DELISTED
Veradigm Inc. Common Stock
MDRX
$4.91M 0.02%
603,400
+102,735
+21% +$839K
OSK icon
605
Oshkosh
OSK
$8.84B
$4.89M 0.02%
66,600
+31,100
+88% +$2.39M
ITGR icon
606
Integer Holdings
ITGR
$4.29B
$4.87M 0.02%
82,500
+3,500
+4% +$234K
BMI icon
607
Badger Meter
BMI
$3.66B
$4.86M 0.02%
74,336
+27,393
+58% +$1.75M
RCKT icon
608
Rocket Pharmaceuticals
RCKT
$374M
$4.85M 0.02%
212,186
-2,238
-1% -$55.1K
RGEN icon
609
Repligen
RGEN
$9.86B
$4.84M 0.02%
32,800
-3,500
-10% -$500K
SYKE
610
DELISTED
SYKES Enterprises Inc
SYKE
$4.82M 0.02%
140,900
COP icon
611
ConocoPhillips
COP
$170B
$4.81M 0.02%
146,463
-106,733
-42% -$4.04M
CTVA icon
612
Corteva
CTVA
$55.6B
$4.8M 0.02%
166,713
+83,775
+101% +$2.36M
DOW icon
613
Dow Inc
DOW
$21.6B
$4.77M 0.02%
101,455
-610
-0.6% -$27.4K
ENTG icon
614
Entegris
ENTG
$19.8B
$4.77M 0.02%
64,200
+58,100
+952% +$3.89M
MSTR icon
615
Strategy Inc
MSTR
$51.5B
$4.74M 0.02%
314,940
+1,000
+0.3% +$13.5K
AFL icon
616
Aflac
AFL
$58.9B
$4.73M 0.02%
130,117
-17,500
-12% -$637K
AMRC icon
617
Ameresco
AMRC
$1.19B
$4.73M 0.02%
141,584
+55,175
+64% +$1.67M
SYY icon
618
Sysco
SYY
$38.1B
$4.72M 0.02%
75,872
-220,781
-74% -$12.8M
SITE icon
619
SiteOne Landscape Supply
SITE
$3.82B
$4.68M 0.02%
38,400
+31,100
+426% +$3.72M
MTG icon
620
MGIC Investment
MTG
$6.14B
$4.66M 0.02%
525,400
ABEV icon
621
Ambev
ABEV
$46.6B
$4.62M 0.02%
2,044,713
-49,224
-2% -$123K
LRCX icon
622
Lam Research
LRCX
$339B
$4.61M 0.02%
138,910
-456,340
-77% -$15.7M
BJ icon
623
BJs Wholesale Club
BJ
$12B
$4.61M 0.02%
110,900
+24,100
+28% +$996K
TRV icon
624
Travelers Companies
TRV
$78.8B
$4.59M 0.02%
42,448
+21,300
+101% +$2.44M
PRGS icon
625
Progress Software
PRGS
$1.79B
$4.59M 0.02%
125,100

Similar funds

Axa's Q3 2020 Portfolio in Review

As of Q3 2020, Axa held 1,391 positions worth $27.7B, up 9% from $25.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Axa's Q3 2020 filing shows 180 new, 435 increased, 508 reduced and 107 closed positions. Its largest new stake was Lemonade: 2,299,647 shares worth $114M. The largest sale was Alibaba, an estimated $63.6M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q3 2020 buy was Lemonade: 2,299,647 shares worth $114M.
  • Axa added most to Meta Platforms (Facebook) in Q3 2020, an estimated $70.5M increase.
  • Axa's biggest Q3 2020 reduction was Alibaba, cutting an estimated $63.6M.
  • Axa fully exited Synchrony in Q3 2020, selling an estimated $10.5M.
  • Axa's ten largest holdings make up 20% of its $27.7B portfolio in Q3 2020.
  • Axa opened 180 new positions and closed 107 in Q3 2020.
  • Axa's portfolio value rose 9% quarter-over-quarter to $27.7B.

Based on Axa's 13F filing for Q3 2020, filed 13 Nov 2020.